A Short Post-Reattachment Ultrasensitive Window of Time in Human Cancer Cells as Therapeutic Target of Prolonged Low-Dose Administration of Specific Compounds
Figure 6
Absence of SUSWoT in MCF7 cells treated with nigericin. Cells were exposed to the indicated concentrations of nigericin, stained, and quantified in a similar fashion as Figures 3(a)–3(d). This figure is representative of three independent experiments.
